http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102670944-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-8965 |
| filingDate | 2011-03-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2015-08-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2015-08-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-102670944-B |
| titleOfInvention | A kind of compound Chinese medicinal preparation for the treatment of ovarian cancer and preparation method thereof |
| abstract | The invention belongs to the field of Chinese medicines, relate to compound Chinese medicinal preparation for the treatment of ovarian cancer and preparation method thereof.The present invention makes solid and liquid dosage form by the extract of the crude drug Radix Astragali, Radix Codonopsis, the Radix Rehmanniae, Herba Scutellariae Barbatae, the Rhizoma Atractylodis Macrocephalae, Radix Asparagi, Fructus Lycii, Cornu Cervi Degelatinatum, Fructus Akebiae, the Radix Aucklandiae, the Radix Paeoniae Alba.Zoopery shows, can alleviate weight loss, leukopenia, improves T lymphocyte function, increase the expression of bax, promote the apoptosis of cancerous cell, play Antineoplastic angiogenesis effect, improve the micro-environmental hypoxia of tumor cell, strengthen ovarian cancer cell to chemotherapy drug susceptibility; Clinical test results shows, can improve the clinical symptoms of Patients with Advanced Ovarian Carcinoma, improves the life quality of patient; Alleviate chemotherapy toxic side effect, improve patient to the toleration of chemotherapy and compliance; Not the controlling of advanced ovarian cancer, relapse rate can be reduced, improve five year survival rate; Without obvious untoward reaction, there is good safety.Be applicable to the treatment of ovarian cancer and ovarian cancer post operation patients undergoing chemotherapy. |
| priorityDate | 2011-03-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 122.